Cargando…
Correction to: Prospective observational study on Pazopanib in patients treated for advanced or metastatic renal cell carcinoma in countries in Asia Pacific, North Africa, and Middle East regions: PARACHUTE study
| Autores principales: | , , , , , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
BioMed Central
2021
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8576870/ https://www.ncbi.nlm.nih.gov/pubmed/34753434 http://dx.doi.org/10.1186/s12885-021-08848-8 |
| _version_ | 1784595964601827328 |
|---|---|
| author | Erman, Mustafa Biswas, Bivas Danchaivijitr, Pongwut Chen, Lingwu Wong, Yoke Fui Hashem, Tarek Lim, Chun Sen Karabulut, Bulent Chung, Hsiao-Jen Chikatapu, Chandrasekhar Ingles, Sara Slimane, Khemaies Kanesvaran, Ravindran |
| author_facet | Erman, Mustafa Biswas, Bivas Danchaivijitr, Pongwut Chen, Lingwu Wong, Yoke Fui Hashem, Tarek Lim, Chun Sen Karabulut, Bulent Chung, Hsiao-Jen Chikatapu, Chandrasekhar Ingles, Sara Slimane, Khemaies Kanesvaran, Ravindran |
| author_sort | Erman, Mustafa |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-8576870 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2021 |
| publisher | BioMed Central |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-85768702021-11-10 Correction to: Prospective observational study on Pazopanib in patients treated for advanced or metastatic renal cell carcinoma in countries in Asia Pacific, North Africa, and Middle East regions: PARACHUTE study Erman, Mustafa Biswas, Bivas Danchaivijitr, Pongwut Chen, Lingwu Wong, Yoke Fui Hashem, Tarek Lim, Chun Sen Karabulut, Bulent Chung, Hsiao-Jen Chikatapu, Chandrasekhar Ingles, Sara Slimane, Khemaies Kanesvaran, Ravindran BMC Cancer Correction BioMed Central 2021-11-09 /pmc/articles/PMC8576870/ /pubmed/34753434 http://dx.doi.org/10.1186/s12885-021-08848-8 Text en © The Author(s) 2021 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data. |
| spellingShingle | Correction Erman, Mustafa Biswas, Bivas Danchaivijitr, Pongwut Chen, Lingwu Wong, Yoke Fui Hashem, Tarek Lim, Chun Sen Karabulut, Bulent Chung, Hsiao-Jen Chikatapu, Chandrasekhar Ingles, Sara Slimane, Khemaies Kanesvaran, Ravindran Correction to: Prospective observational study on Pazopanib in patients treated for advanced or metastatic renal cell carcinoma in countries in Asia Pacific, North Africa, and Middle East regions: PARACHUTE study |
| title | Correction to: Prospective observational study on Pazopanib in patients treated for advanced or metastatic renal cell carcinoma in countries in Asia Pacific, North Africa, and Middle East regions: PARACHUTE study |
| title_full | Correction to: Prospective observational study on Pazopanib in patients treated for advanced or metastatic renal cell carcinoma in countries in Asia Pacific, North Africa, and Middle East regions: PARACHUTE study |
| title_fullStr | Correction to: Prospective observational study on Pazopanib in patients treated for advanced or metastatic renal cell carcinoma in countries in Asia Pacific, North Africa, and Middle East regions: PARACHUTE study |
| title_full_unstemmed | Correction to: Prospective observational study on Pazopanib in patients treated for advanced or metastatic renal cell carcinoma in countries in Asia Pacific, North Africa, and Middle East regions: PARACHUTE study |
| title_short | Correction to: Prospective observational study on Pazopanib in patients treated for advanced or metastatic renal cell carcinoma in countries in Asia Pacific, North Africa, and Middle East regions: PARACHUTE study |
| title_sort | correction to: prospective observational study on pazopanib in patients treated for advanced or metastatic renal cell carcinoma in countries in asia pacific, north africa, and middle east regions: parachute study |
| topic | Correction |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8576870/ https://www.ncbi.nlm.nih.gov/pubmed/34753434 http://dx.doi.org/10.1186/s12885-021-08848-8 |
| work_keys_str_mv | AT ermanmustafa correctiontoprospectiveobservationalstudyonpazopanibinpatientstreatedforadvancedormetastaticrenalcellcarcinomaincountriesinasiapacificnorthafricaandmiddleeastregionsparachutestudy AT biswasbivas correctiontoprospectiveobservationalstudyonpazopanibinpatientstreatedforadvancedormetastaticrenalcellcarcinomaincountriesinasiapacificnorthafricaandmiddleeastregionsparachutestudy AT danchaivijitrpongwut correctiontoprospectiveobservationalstudyonpazopanibinpatientstreatedforadvancedormetastaticrenalcellcarcinomaincountriesinasiapacificnorthafricaandmiddleeastregionsparachutestudy AT chenlingwu correctiontoprospectiveobservationalstudyonpazopanibinpatientstreatedforadvancedormetastaticrenalcellcarcinomaincountriesinasiapacificnorthafricaandmiddleeastregionsparachutestudy AT wongyokefui correctiontoprospectiveobservationalstudyonpazopanibinpatientstreatedforadvancedormetastaticrenalcellcarcinomaincountriesinasiapacificnorthafricaandmiddleeastregionsparachutestudy AT hashemtarek correctiontoprospectiveobservationalstudyonpazopanibinpatientstreatedforadvancedormetastaticrenalcellcarcinomaincountriesinasiapacificnorthafricaandmiddleeastregionsparachutestudy AT limchunsen correctiontoprospectiveobservationalstudyonpazopanibinpatientstreatedforadvancedormetastaticrenalcellcarcinomaincountriesinasiapacificnorthafricaandmiddleeastregionsparachutestudy AT karabulutbulent correctiontoprospectiveobservationalstudyonpazopanibinpatientstreatedforadvancedormetastaticrenalcellcarcinomaincountriesinasiapacificnorthafricaandmiddleeastregionsparachutestudy AT chunghsiaojen correctiontoprospectiveobservationalstudyonpazopanibinpatientstreatedforadvancedormetastaticrenalcellcarcinomaincountriesinasiapacificnorthafricaandmiddleeastregionsparachutestudy AT chikatapuchandrasekhar correctiontoprospectiveobservationalstudyonpazopanibinpatientstreatedforadvancedormetastaticrenalcellcarcinomaincountriesinasiapacificnorthafricaandmiddleeastregionsparachutestudy AT inglessara correctiontoprospectiveobservationalstudyonpazopanibinpatientstreatedforadvancedormetastaticrenalcellcarcinomaincountriesinasiapacificnorthafricaandmiddleeastregionsparachutestudy AT slimanekhemaies correctiontoprospectiveobservationalstudyonpazopanibinpatientstreatedforadvancedormetastaticrenalcellcarcinomaincountriesinasiapacificnorthafricaandmiddleeastregionsparachutestudy AT kanesvaranravindran correctiontoprospectiveobservationalstudyonpazopanibinpatientstreatedforadvancedormetastaticrenalcellcarcinomaincountriesinasiapacificnorthafricaandmiddleeastregionsparachutestudy |